Skip to content
AusGrant
National Open UK-UKRI-UK-UKRI-58FE67FBF1B3EADECAC0614A20D64FDC

Advancing innovation in accelerated cancer diagnosis

UK Research and Innovation (UKRI) · Competitive · Research & Development

At a glance

Advancing innovation in accelerated cancer diagnosis is a national competitive grant from UK Research and Innovation for the research & development sector. Funding is up to £25.4M. Eligible applicants: See the official UKRI opportunity page; eligibility varies by council and call - most require UK-based researchers or organisations. The application deadline is October 28, 2026. Apply via the official listing at www.ukri.org.

Amount
Up to £25.4M
Deadline
28 Oct 2026
Type
Competitive
Status
Open

About this program

Funding opportunity Funding opportunity: Advancing innovation in accelerated cancer diagnosis Opportunity status: Open Funders: Innovate UK Co-funders: Office for Life Sciences’ (OLS) Funding type: Grant Total fund: £25,400,000 Publication date: 20 August 2026 Opening date: 1 September 2026 9:30am UK time Closing date: 28 October 2026 11:00am UK time See the full opportunity details on the Innovation Funding Service . Innovate UK, on behalf of the OLS Cancer Healthcare Goals programme, will invest up to £25.4 million, to support the clinical validation and evaluation of early cancer diagnostic technologies and devices. Eligibility summary This competition is open to collaborations only. To lead a collaborative project your organisation must be: a UK registered business an academic institution an NHS organisation The consortium must contain at least one UK registered micro, small or medi...

Who can apply

See the official UKRI opportunity page; eligibility varies by council and call - most require UK-based researchers or organisations.

How to apply

Apply through the UKRI Funding Service as directed on the official opportunity page linked below.

Apply at official source